Newbridge Financial Services Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100
Closed -$9K 1608
2021
Q4
$9K Buy
+100
New +$6.59K ﹤0.01% 953

Newbridge Financial Services Group's ARNA Position: Q1 2022 in Review

Newbridge Financial Services Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 100 shares — an estimated $9K sold.

Newbridge Financial Services Group first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $9K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Newbridge Financial Services Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Newbridge Financial Services Group sold 100 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $9K.
  • Newbridge Financial Services Group first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
  • Newbridge Financial Services Group's Arena Pharmaceuticals Inc position peaked at $9K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Newbridge Financial Services Group's 13F filing for Q1 2022, filed 26 Apr 2022.